News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-07 3:3:29 am Turn $500 into a Fortune: 3 Top Stock Picks for March’s Million-Dollar Rally InvestorPlace
2024-02-20 5:0:0 am Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary Business Wire
2024-02-15 4:30:0 am Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023 Business Wire
2024-02-01 4:30:0 am Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024 Business Wire
2024-01-10 4:33:0 am Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older Business Wire
2024-01-08 4:30:0 am Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook Business Wire
2023-12-21 4:30:0 am Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference Business Wire
2023-12-18 4:30:0 am Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines Business Wire
   

Please consider a small donation if you think this website provides you with relevant information